Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 4 Lung Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Pain 2 Lymphoma 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Postoperative Hemorrhage 1 Polyposis, Gastric 1 Oropharyngeal Neoplasms 1 Nerve Block 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Musculoskeletal Diseases 1 Multiple Myeloma 1 Mouth Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Hairy Cell 1 Leukemia 1 Leiomyoma 1 Hypotension 1 Hodgkin Disease 1

Interventions

Magnetic Resonance Spectroscopy 17 Iodine-131 16 lenvatinib 13 trametinib 12 Thyrotropin Alfa 11 Sorafenib 11 pembrolizumab 10 dabrafenib 10 Paclitaxel 9 vandetanib 8 Thyroxine 8 Surgical Procedures, Operative 7 Sunitinib 7 selpercatinib 6 cabozantinib 6 Nivolumab 6 Fluorodeoxyglucose F18 6 Everolimus 6 pazopanib 5 Vemurafenib 5 Thyroidectomy 5 Specimen Handling 5 Saline Solution 5 Radiotherapy 5 Radiofrequency Ablation 5 Cyclophosphamide 5 Cisplatin 5 Biopsy 5 apatinib 4 anlotinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thyroid Neoplasms × Epinephrine × Clear all

NCT02112370 2017-08-04

REBT

Seoul National University Hospital

Phase 3 Completed

148 enrolled 17 charts

Goiter, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡